COMMON STOCK AND WARRANT PURCHASE AGREEMENTCommon Stock and Warrant Purchase Agreement • October 14th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 14th, 2020 Company Industry JurisdictionThis Common Stock and Warrant Purchase Agreement, dated as of [ ], 201[ ] (this “Agreement”), is entered into by and among RespireRx Pharmaceuticals Inc. (the “Company”), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the “Investors”). This Agreement is expected to be one of several like agreements, collectively the “Common Stock and Warrant Purchase Agreements.”
COMMON STOCK AND WARRANT PURCHASE AGREEMENTCommon Stock and Warrant Purchase Agreement • October 14th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 14th, 2020 Company Industry JurisdictionThis Common Stock and Warrant Purchase Agreement, dated as of [ ], 2016 (this “Agreement”), is entered into by and among RespireRx Pharmaceuticals Inc., (the “Company”), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the “Investors”). This Agreement is expected to be one of several like agreements, collectively the “Common Stock and Warrant Purchase Agreements.”
COMMON STOCK AND WARRANT PURCHASE AGREEMENTCommon Stock and Warrant Purchase Agreement • October 14th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 14th, 2020 Company Industry JurisdictionThis Common Stock and Warrant Purchase Agreement, dated as of [ ], 2018 (this “Agreement”), is entered into by and among RespireRx Pharmaceuticals Inc. (the “Company”), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the “Investors”). This Agreement is expected to be one of several like agreements, collectively the “Common Stock and Warrant Purchase Agreements.”
COMMON STOCK AND WARRANT PURCHASE AGREEMENTCommon Stock and Warrant Purchase Agreement • March 16th, 2017 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 16th, 2017 Company Industry JurisdictionThis Common Stock and Warrant Purchase Agreement, dated as of [ ], 201[ ] (this “Agreement”), is entered into by and among RespireRx Pharmaceuticals Inc. (the “Company”), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the “Investors”). This Agreement is expected to be one of several like agreements, collectively the “Common Stock and Warrant Purchase Agreements.”
COMMON STOCK AND WARRANT PURCHASE AGREEMENTCommon Stock and Warrant Purchase Agreement • January 11th, 2016 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 11th, 2016 Company Industry JurisdictionThis Common Stock and Warrant Purchase Agreement, dated as of [ ], 201[ ] (this “Agreement”), is entered into by and among RespireRx Pharmaceuticals Inc., formerly Cortex Pharmaceuticals, Inc., (the “Company”), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the “Investors”). This Agreement is expected to be one of several like agreements, collectively the “Common Stock and Warrant Purchase Agreements.”
SECOND AMENDED AND RESTATED COMMON STOCK AND WARRANT PURCHASE AGREEMENTCommon Stock and Warrant Purchase Agreement • August 31st, 2015 • Cortex Pharmaceuticals Inc/De/ • Pharmaceutical preparations • New York
Contract Type FiledAugust 31st, 2015 Company Industry JurisdictionThis Common Stock and Warrant Purchase Agreement, dated as of [ ], 2015 (this “Agreement”), is entered into by and among Cortex Pharmaceuticals, Inc. (the “Company”), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the “Investors”). This Agreement is expected to be one of several like agreements, collectively the “Common Stock and Warrant Purchase Agreements.”